Christopher Tate
E480557
Christopher Tate is a scientist and entrepreneur best known as a co-founder of Heptares Therapeutics, a biotechnology company specializing in G protein–coupled receptor (GPCR) drug discovery.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Christopher Tate canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4850481 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Christopher Tate Context triple: [Heptares Therapeutics, foundedBy, Christopher Tate]
-
A.
Christopher Clayton
Christopher Clayton is a distinguished geoscientist recognized for his significant contributions to the Earth sciences, as evidenced by his receipt of the prestigious William Smith Medal.
-
B.
Christopher Blake
Christopher Blake is a stage play written by American playwright Moss Hart, best known for its dramatic exploration of family and marital conflict.
-
C.
Martin Hunter
Martin Hunter is a film editor best known for his work on the science-fiction horror movie "Event Horizon."
-
D.
John Hudson
John Hudson was one of the sons of the English explorer Henry Hudson, who is believed to have accompanied his father on his final, ill-fated voyage in search of a Northwest Passage.
-
E.
John Hudson
John Hudson is a distinguished geologist recognized for his significant contributions to the field, as evidenced by honors such as the William Smith Medal.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Christopher Tate Target entity description: Christopher Tate is a scientist and entrepreneur best known as a co-founder of Heptares Therapeutics, a biotechnology company specializing in G protein–coupled receptor (GPCR) drug discovery.
-
A.
Christopher Clayton
Christopher Clayton is a distinguished geoscientist recognized for his significant contributions to the Earth sciences, as evidenced by his receipt of the prestigious William Smith Medal.
-
B.
Christopher Blake
Christopher Blake is a stage play written by American playwright Moss Hart, best known for its dramatic exploration of family and marital conflict.
-
C.
Martin Hunter
Martin Hunter is a film editor best known for his work on the science-fiction horror movie "Event Horizon."
-
D.
John Hudson
John Hudson was one of the sons of the English explorer Henry Hudson, who is believed to have accompanied his father on his final, ill-fated voyage in search of a Northwest Passage.
-
E.
John Hudson
John Hudson is a distinguished geologist recognized for his significant contributions to the field, as evidenced by honors such as the William Smith Medal.
- F. None of above. chosen
Statements (30)
| Predicate | Object |
|---|---|
| instanceOf |
biochemist
ⓘ
entrepreneur ⓘ scientist ⓘ structural biologist ⓘ |
| coFounded | Heptares Therapeutics NERFINISHED ⓘ |
| countryOfCitizenship | United Kingdom ⓘ |
| employer |
Heptares Therapeutics
NERFINISHED
ⓘ
MRC Laboratory of Molecular Biology NERFINISHED ⓘ |
| fieldOfWork |
G protein–coupled receptor biology
ⓘ
biochemistry ⓘ drug discovery ⓘ membrane protein biology ⓘ structural biology ⓘ |
| focusesOn | G protein–coupled receptor drug discovery ⓘ |
| foundedOrganizationType | biotechnology company ⓘ |
| hasAcademicAffiliation | MRC Laboratory of Molecular Biology NERFINISHED ⓘ |
| hasRole |
Chief Scientific Officer of Heptares Therapeutics
ⓘ
scientific founder of Heptares Therapeutics ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
co-founding Heptares Therapeutics
ⓘ
research on G protein–coupled receptors ⓘ |
| language | English ⓘ |
| notableWork |
determination of GPCR structures
ⓘ
development of stabilized GPCR technology (StaR) at Heptares Therapeutics ⓘ |
| researchInterest |
membrane protein crystallography
ⓘ
stabilized GPCRs ⓘ structure-based drug design ⓘ |
| workLocation |
Cambridge
NERFINISHED
ⓘ
United Kingdom ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Christopher Tate Description of subject: Christopher Tate is a scientist and entrepreneur best known as a co-founder of Heptares Therapeutics, a biotechnology company specializing in G protein–coupled receptor (GPCR) drug discovery.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.